Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-25-000588
Filing Date
2025-02-14
Accepted
2025-02-14 13:27:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12583
  Complete submission text file 0000930413-25-000588.txt   14248
Mailing Address 2 OVERHILL ROAD SCARSDALE NY 10583
Business Address 2 OVERHILL ROAD SCARSDALE NY 10583 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SCHEDULE 13G/A

Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Subject) CIK: 0001892500 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93839 | Film No.: 25626182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)